Integrative Biology Journals

Natural Products and Bioprospecting ›› 2025, Vol. 15 ›› Issue (6): 64-64.DOI: 10.1007/s13659-025-00549-0

• Original Article • Previous Articles     Next Articles

Lobetyolin, an anti-AD factor from the diet campanulaceae source, metabolism regulation and target exploration

Wen Huang1, Yihan Liu1, Haixin Jiang1, Dongxue Guo1, Yi Song1, Junqi Wang1, Luqi Li2, Qiang Zhang1   

  1. 1. Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, 712100, China;
    2. Life Science Research Core Services, Northwest A&F University, Yangling, 712100, China
  • Received:2025-08-04 Online:2026-01-12
  • Contact: Qiang Zhang Email:E-mail:zhangq@nwsuaf.edu.cn
  • Supported by:
    This research was funded by the key research and development program of Shaanxi Province (grant number 2024NC-YBXM-180) and the Science and Technology Program of the Yangling Demonstration Zone of Agricultural Hi-Tech Industries (grant number 2024SF-01).

Lobetyolin, an anti-AD factor from the diet campanulaceae source, metabolism regulation and target exploration

Wen Huang1, Yihan Liu1, Haixin Jiang1, Dongxue Guo1, Yi Song1, Junqi Wang1, Luqi Li2, Qiang Zhang1   

  1. 1. Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, 712100, China;
    2. Life Science Research Core Services, Northwest A&F University, Yangling, 712100, China
  • 通讯作者: Qiang Zhang Email:E-mail:zhangq@nwsuaf.edu.cn
  • 基金资助:
    This research was funded by the key research and development program of Shaanxi Province (grant number 2024NC-YBXM-180) and the Science and Technology Program of the Yangling Demonstration Zone of Agricultural Hi-Tech Industries (grant number 2024SF-01).

Abstract: Bioactive compounds from food-compatible medicinal herbs have shown promise as preventive agents against age-related neurodegenerative conditions, particularly Alzheimer's disease (AD). The present work aimed to find Lobetyolin as a new suppressor of Aβ aggregation and its interventions on abnormal metabolism in AD. Aβ-expressing Caenorhabditis elegans (strain CL4176) and wild-type worms were employed to evaluate paralysis onset, lifespan, cerebral Aβ deposition, and intracellular reactive oxygen species (ROS) after Lobetyolin administration. Untargeted ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) metabolomics coupled with RNA-seq transcriptomics was carried out to profile systemic metabolic and gene-expression changes. Differential metabolites and transcripts were subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and pathway-impact analyses; hub targets were prioritized by integrating enrichment scores with in-silico docking. Lobetyolin (12.5-50 μM) markedly protected C. elegans from Aβ-driven toxicity and oxidative stress. In CL2006 worms, β-amyloid deposits fell by 54.8 ± 9.4%, while paralysis in CL4176 was delayed by 20.9 ± 4.5%. Lifespan increased by up to 18.2% in CL4176 and 25.0% in wild-type N2 worms. Concomitantly, intracellular ROS declined maximally by 28.1 ± 8.9% (N2) and 22.4 ± 3.8% (CL4176). Integrative metabolomic-transcriptomic analyses, validated by RT-qPCR, revealed selective remodeling of glutathione metabolism: gst-38 expression was suppressed, whereas gst-1 was elevated. Lobetyolin confers neuroprotective and geroprotective benefits in vivo, primarily through reprogramming glutathione-centered redox metabolism and selectively modulating glutathione-S-transferases (GST) isoforms. These findings position Lobetyolin as a promising dietary lead compound for AD prevention and healthy aging interventions.

Key words: Lobetyolin, AD prevention, Metabolic intervention, Glutathione metabolism, gst-38, gst-1

摘要: Bioactive compounds from food-compatible medicinal herbs have shown promise as preventive agents against age-related neurodegenerative conditions, particularly Alzheimer's disease (AD). The present work aimed to find Lobetyolin as a new suppressor of Aβ aggregation and its interventions on abnormal metabolism in AD. Aβ-expressing Caenorhabditis elegans (strain CL4176) and wild-type worms were employed to evaluate paralysis onset, lifespan, cerebral Aβ deposition, and intracellular reactive oxygen species (ROS) after Lobetyolin administration. Untargeted ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) metabolomics coupled with RNA-seq transcriptomics was carried out to profile systemic metabolic and gene-expression changes. Differential metabolites and transcripts were subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and pathway-impact analyses; hub targets were prioritized by integrating enrichment scores with in-silico docking. Lobetyolin (12.5-50 μM) markedly protected C. elegans from Aβ-driven toxicity and oxidative stress. In CL2006 worms, β-amyloid deposits fell by 54.8 ± 9.4%, while paralysis in CL4176 was delayed by 20.9 ± 4.5%. Lifespan increased by up to 18.2% in CL4176 and 25.0% in wild-type N2 worms. Concomitantly, intracellular ROS declined maximally by 28.1 ± 8.9% (N2) and 22.4 ± 3.8% (CL4176). Integrative metabolomic-transcriptomic analyses, validated by RT-qPCR, revealed selective remodeling of glutathione metabolism: gst-38 expression was suppressed, whereas gst-1 was elevated. Lobetyolin confers neuroprotective and geroprotective benefits in vivo, primarily through reprogramming glutathione-centered redox metabolism and selectively modulating glutathione-S-transferases (GST) isoforms. These findings position Lobetyolin as a promising dietary lead compound for AD prevention and healthy aging interventions.

关键词: Lobetyolin, AD prevention, Metabolic intervention, Glutathione metabolism, gst-38, gst-1